A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention

Table 3 Odds ratio of likelihood of being seen at HCP before and after the educational campaign

	Odds of BRCA1 or BRCA2 testing
Before the educational campaign
Endometroid or clear cell	1.00 (ref)
Serous cancer	1.27 (0.96–1.68)
After the educational campaign
Endometrioid or clear cell	1.00 (ref)
Serous cancer	4.70 (2.89–7.62)

ISSN: 1471-2407